Sodium Acetate Injection · 3,824 days since initial FDA posting
Brand: SODIUM ACETATE
FDA lists Sodium Acetate Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Sodium Acetate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Sodium Acetate Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)
- Package NDC
- 63323-032-00
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Mar 23, 2016
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Total Parenteral Nutrition
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory
Nearby, Other Sodium Shortage Records
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Milla Pharmaceuticals
Injection
Sodium Acetate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Acetate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Acetate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.